Exelixis (NasdaqGS:EXEL) has submitted an FDA application for zanzalintinib, its next generation cancer therapy, in metastatic colorectal cancer. The filing covers use of zanzalintinib in combination ...
A new AI model from Google DeepMind called AlphaGenome can predict how DNA mutations affect biological processes, helping pinpoint genes linked to diseases and speeding up drug discovery.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results